CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Minerva Surgical Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Minerva Surgical Inc
101 Saginaw Drive
Phone: (650) 284-3500p:650 284-3500 REDWOOD CITY, CA  94063  United States Ticker: UTRSUTRS
This company ceased filing statements with the SEC on 1/4/2024.
On 2/9/2023, the Company was acquired by Accelmed Partners II L.P.
Business Summary
Minerva Surgical, Inc. is a uterine health company. The Company is engaged in manufacturing and distribution of invasive gynecologic technologies. The Company is focused on improving women's health and quality of life by providing access to minimally invasive, technologically advanced, and innovative solutions for early detection, treatment, and management of uterine conditions. It delivers devices that treat the root causes of Abnormal Uterine Bleeding (AUB) in both the normal and irregular shaped uterus. The Company's products include Minerva ES Endometrial Ablation System (Minerva ES), Genesys HTA Endometrial Ablation System (Genesys HTA), Symphion Operative Hysteroscopy System (Symphion), Resectr Tissue Resection Device (Resectr), and Disposable Hysteroscope. Minerva ES is an endometrial ablation device that utilizes its PlasmaSense technology. Symphion System is designed to transform the way you see and remove uterine fibroids and polyps.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Industries
SIC Code Description
3829 Measuring and controlling devices, not elsewhere classified
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board UriGeiger 56 7/1/2023 2/9/2023
President, Chief Executive Officer, Director ToddUsen 56 1/2/2023 1/2/2023
Chief Financial Officer Joel R.Jung 65 1/1/2021
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 174 (As of 12/31/2022)
Outstanding Shares: 8,878,582 (As of 11/2/2023)
Shareholders: 119
Stock Exchange: OTC
Federal Tax Id: 263422906
Fax Number: (302) 655-5049


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, January 30, 2025